François Moreau-Gaudry Selected Research

Leukemia

3/2003

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

François Moreau-Gaudry Research Topics

Disease

11	Neoplasms (Cancer) 08/2022 - 10/2007
9	Erythropoietic Porphyria (Congenital Erythropoietic Porphyria) 11/2020 - 01/2008
4	Porphyrias (Porphyria) 03/2024 - 06/2008
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 03/2003
3	Hemolytic Anemia 11/2020 - 07/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019 - 10/2012
3	Adenocarcinoma 01/2019 - 10/2012
3	Erythropoietic Protoporphyria 04/2014 - 09/2003
2	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 08/2022
2	Hemolysis 11/2020 - 12/2019
2	Iron Overload 11/2020 - 12/2019
2	Anemia 11/2020 - 12/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2017
2	Primary hyperoxaluria type 1 10/2019 - 01/2019
2	Liver Failure 07/2011 - 06/2008
1	Prostatic Neoplasms (Prostate Cancer) 03/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Muscular Dystrophies (Muscular Dystrophy) 10/2021
1	Obesity 01/2021
1	Congenital Hemolytic Anemia (Hemolytic Anemia, Congenital) 12/2019
1	Renal Insufficiency (Renal Failure) 10/2019
1	Nephrocalcinosis 10/2019
1	Urolithiasis 10/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Teratoma (Teratoid Tumor) 01/2017
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2016
1	Liver Diseases (Liver Disease) 07/2011
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2011
1	Liver Neoplasms (Liver Cancer) 08/2009
1	Hepatocellular Carcinoma (Hepatoma) 10/2007
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2007
1	Infections 01/2007
1	Leukemia 03/2003
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 03/2003

Drug/Important Bio-Agent (IBA)

8	Heme (Haem)IBA 03/2024 - 09/2003
7	EnzymesIBA 10/2019 - 09/2003
5	PorphyrinsIBA 03/2024 - 06/2008
5	Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA 11/2020 - 01/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2019
3	Messenger RNA (mRNA)IBA 01/2023 - 10/2007
3	protoporphyrin IXIBA 08/2022 - 09/2003
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2019
3	Tyrosine Kinase InhibitorsIBA 07/2013 - 03/2003
2	IronIBA 11/2020 - 12/2019
2	OxalatesIBA 10/2019 - 01/2019
2	Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)IBA 10/2019 - 01/2019
2	Capsaicin (Zostrix)FDA Link 01/2019 - 01/2017
2	ResveratrolIBA 01/2019 - 01/2017
2	Ferrochelatase (Heme Synthetase)IBA 04/2014 - 09/2003
2	Proteins (Proteins, Gene)FDA Link 10/2012 - 03/2003
2	Imatinib Mesylate (Gleevec)FDA Link 06/2007 - 03/2003
1	AcidsIBA 08/2022
1	Chimeric Antigen ReceptorsIBA 10/2021
1	Ferritins (Ferritin)IBA 01/2021
1	SodiumIBA 01/2021
1	AlbuminsIBA 01/2021
1	DeferiproneIBA 11/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	HepcidinsIBA 12/2019
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	SaltsIBA 01/2019
1	CalciumIBA 01/2019
1	Calcium OxalateIBA 01/2019
1	SurvivinIBA 01/2017
1	LuciferasesIBA 01/2017
1	Nucleoside-Diphosphate KinaseIBA 01/2017
1	Protein Kinases (Protein Kinase)IBA 01/2017
1	Gemcitabine FDA Link 01/2017
1	3,3',4,5'-tetrahydroxystilbeneIBA 01/2017
1	sulforaphaneIBA 01/2017
1	Dual-Specificity PhosphatasesIBA 10/2016
1	Antisense OligonucleotidesIBA 04/2014
1	Ganciclovir (Cytovene)FDA LinkGeneric 10/2012
1	Mucin-4IBA 10/2012
1	Surface Antigens (Surface Antigen)IBA 10/2012
1	Busulfan (Busulfex)FDA Link 07/2011
1	Epidermal Growth Factor (EGF)IBA 08/2009
1	Heparin (Liquaemin)FDA LinkGeneric 08/2009
1	Cyclin D1IBA 08/2009
1	DNA HelicasesIBA 10/2007
1	AgarIBA 10/2007
1	Adenosine Triphosphatases (ATPase)IBA 10/2007
1	CeramidesIBA 10/2007
1	Small Interfering RNA (siRNA)IBA 10/2007
1	beta CateninIBA 10/2007
1	CytokinesIBA 06/2007
1	nilotinib FDA Link 06/2007
1	Proteasome InhibitorsIBA 04/2007
1	Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA 01/2007
1	Alkylating AgentsIBA 01/2007
1	Complementary DNA (cDNA)IBA 03/2003
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2003

Therapy/Procedure

8	Therapeutics 08/2022 - 06/2008
3	Drug Therapy (Chemotherapy) 01/2019 - 04/2007
2	Radiotherapy 08/2022 - 01/2019
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 07/2011 - 06/2008
1	Endovascular Procedures 01/2019
1	Liver Transplantation 06/2008